Trimel to Present at Upcoming Investor Conference
(firmenpresse) - TORONTO, ONTARIO -- (Marketwire) -- 06/11/12 -- Trimel Pharmaceuticals Corporation (TSX: TRL) ("Trimel" or "the Company") today announced today that executive management will participate in the Bloom Burton & Co. Healthcare Investor Conference to be held June 21, 2012 at the Toronto Board of Trade. Mr. Tom Rossi, President and Chief Operating Officer, and Mr Kenneth Howling, Chief Financial Officer, are scheduled to present an overview of the Company and its product pipeline at 2:00 pm EDT. The presentation materials will also be available on the Trimel website at .
For further information regarding Trimel Pharmaceuticals Corporation, please contact either Bruce Brydon, Chairman of the Board and Chief Executive Officer at (416) 679-0711 or Kenneth Howling, Chief Financial Officer at (416) 679-0536 or via email at .
About Trimel
Trimel Pharmaceuticals Corporation (TSX: TRL) - Developing medications for Female Sexual Health and conditions related to Aging, and Well Being. Trimel is developing multiple product opportunities, including CompleoTRTâ„¢, a bio-adhesive intranasal Testosterone gel currently in Phase III clinical testing in the United States. CompleoTRTâ„¢ is under investigation for the treatment of male hypogonadism, a condition commonly referred to as "Low T". For more information, please visit .
Contacts:
Trimel Pharmaceuticals Corporation
Kenneth Howling
Chief Financial Officer
(416) 679-0536
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.06.2012 - 09:48 Uhr
Sprache: Deutsch
News-ID 1122988
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
TORONTO, ONTARIO
Phone:
Kategorie:
Healthcare
Anmerkungen:
Diese Pressemitteilung wurde bisher 142 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Trimel to Present at Upcoming Investor Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Trimel Pharmaceuticals Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
